The herpes simplex virus type 1 (HSV-1) latency-associated transcripts (LATs) accumulate in neuronal nuclei of latently infected ganglia. Explant reactivation kinetics of LAT deletion mutants in the mouse eye model have suggested a role for the LATs in the reactivation process. This report describes the construction and characterization of an HSV-1 strain HFEM mutant, TB1, disrupted within both copies of the LAT gene. TB1 contains a 440-base-pair segment of bacteriophage lambda DNA in place of a 168-base-pair deletion within the transcribed portion of the LAT gene. The 2.0-kilobase LAT was not produced after infection of tissue culture cells with TB1, but a 0.7-to 0.8-kilobase RNA was expressed. TB1 did establish latent infection after corneal inoculation as efficiently as the parental virus, and its reactivation kinetics from explanted ganglia were similar to those of HFEM. During latent infection with TB1, HSV-1 transcripts were not detectable. Rescuant virus (TB1-R) contained intact LAT genes, synthesized full-length LAT transcripts during productive infection in tissue culture, and reactivated from ganglionic explants of latently infected mice with normal kinetics. Thus, any function these transcripts have in the reactivation process appears to include the region between the putative LAT promoter and the disruption in TB1-a region of approximately 1,600 nucleotides, 800 of which encode the LATs.
The herpes simplex virus type 1 (HSV-1) latency-associated transcripts (LATs) accumulate in neuronal nuclei of latently infected ganglia. Explant reactivation kinetics of LAT deletion mutants in the mouse eye model have suggested a role for the LATs in the reactivation process. This report describes the construction and characterization of an HSV-1 strain HFEM mutant, TB1, disrupted within both copies of the LAT gene. TB1 contains a 440-base-pair segment of bacteriophage lambda DNA in place of a 168-base-pair deletion within the transcribed portion of the LAT gene. The 2.0-kilobase LAT was not produced after infection of tissue culture cells with TB1, but a 0.7-to 0.8-kilobase RNA was expressed. TB1 did establish latent infection after corneal inoculation as efficiently as the parental virus, and its reactivation kinetics from explanted ganglia were similar to those of HFEM. During latent infection with TB1, HSV-1 transcripts were not detectable. Rescuant virus (TB1-R) contained intact LAT genes, synthesized full-length LAT transcripts during productive infection in tissue culture, and reactivated from ganglionic explants of latently infected mice with normal kinetics. Thus, any function these transcripts have in the reactivation process appears to include the region between the putative LAT promoter and the disruption in TB1-a region of approximately 1,600 nucleotides, 800 of which encode the LATs.
Human infection with herpes simplex virus (HSV) is characterized by the persistence of viral genetic information in neurons of the peripheral nervous system for the lifetime of the individual in the absence of overt disease (6, 13, 23) . This latent state can be interrupted by reactivation of virus that results in productive infection and recurrent disease.
Mouse models of HSV latency have been extremely informative (reviewed in reference 6) and have revealed that the viral genetic information in trigeminal ganglia exists primarily as an episome (14, 17) . Transcription of HSV type 1 (HSV-1) during latency is limited to one region of the viral genome located in the repeat regions IRL and TRL (2, 18, 19, 24) . Three predominately poly(A)-transcripts of 2.0, 1.5, and 1.45 kilobases (kb) are present in latently infected neurons (19, 26, 27) . The two smaller latency-associated transcripts (LATs) are spliced (27, 28) . These LATs (24) map to a region of the inverted repeats that partially overlaps with the alpha gene, ICPO (alpha 0). However, ICPO and the LATs are transcribed from different DNA strands of the viral genome (19, 24) . Since the LATs are found in the latently infected cell, it is important to know what function(s), if any, they serve in the establishment, maintenance, or reactivation from the latent state.
An HSV-1 x HSV-2 recombinant with predominately HSV-1 genetic material which does not express LATs established latent infections after mouse footpad infection (8) . Since mutant and wild-type viruses were recovered from lumbar ganglia of infected mice with equal frequency at similar times after explantation, it was concluded that the LATs are dispensable for the establishment of latent infec- tions. However, studies with an HSV-1 deletion mutant virus (1704), while supporting a nonessential role in establishment of latent infection, have suggested a role for the LATs in the reactivation process (22) .
HSV-1 variant 1704 possesses a 3.8-kb deletion in IRL and adjacent unique DNA sequences and a 1.2-kb deletion in TRL (11) . Variant 1704 does not express LATs in tissue culture or latent infection in mice (22) . Although 1704 did establish latent infections in mice, explant reactivation of virus was significantly slower than that of wild-type parental strain 17+. Moreover, Leib et al. (9) have recently reported that a strain KOS-derived LAT-deletion mutant (dl LAT 1.8) reactivates from explants less efficiently than its LAT+ parent. Therefore, the data suggest that the LATs play a role in mediating reactivation.
We constructed a defined mutant containing a single disruption between nucleotides +839 and +1007 (with respect to the proposed RNA start site [29] ) of the 1.5-to 2.0-kb LATs to study their role in latency and reactivation. In this communication, we describe the production and characterization of the biochemical and biological properties of an HSV-1 strain HFEM-derived mutant that does not express full-length 1.5-to 2.0-kb LATs because of a replacement mutation. This mutant, TB1, expresses a 0.7-to 0. (21) . Strains 17+, 1704, and F were also used (22) . Plaque purifications were done by inoculating CV-1 cells with dilutions of cell-free virus and overlaying with methylcellulose (2%, 4,000 cP). DNA was isolated from virions as described by Pignatti et al. (16) .
Plasmids and DNA transfections, isolation of mutants, and DNA dot-blot analysis. The tk-specific probe was pHSV106 (a gift from S. McKnight; described in reference 1). Plasmid PstI-MluI is a pUC18 derivative that contains the 3-kb PstI-MluI fragment of the HSV-1 genome spanning the LATs (see reference 21) . Plasmid X-PstI-MluI contains a 440-bp HpaI fragment of lambda DNA replacing the 180-bp HpaI fragment within PstI-MluI (Fig. 1) . The 180-bp HSV sequence, deleted in X-PstI-MluI, was cloned into pUC18 and is called Hpa-Hpa-0.180. The LAT-specific probe was a pUC18 plasmid containing the 1.8-kb HSV sequence between the PstI and HpaI sites shown in Fig. 1 . The alpha 0-specific probe, called MluI-BamHI, is a pUC18 plasmid containing the 1.9-kb MluI-BamHI fragment (Fig. 1) h, the paraffin oil was removed with a chloroform wash and the slides were washed, dehydrated in ethanol, dipped in NTB-2 nuclear track emulsion (Eastman Kodak Co., Rochester, N.Y.), and exposed for 1 to 2 days at 4°C. After processing with D19 developer (Kodak) and fixer (Kodak), the sections were stained with hematoxylin and eosin. Control ganglia obtained from uninfected BALB/c mice were similarly processed. Plaque purification. When cytopathic effects were first noted in monolayers during explant reactivation of TB1, fresh media containing human immune serum globulin (Cutter Gamastan; 3 [lI/ml) were added to prevent extracellular spread of the virus. After 24 h, isolated plaques were picked to grow viral stocks for DNA extraction as described below.
DNA and RNA analysis. Restriction analysis of virion DNA was done as follows: Virion DNA was prepared (1), digested to completion with restriction endonucleases according to the specifications of the manufacturers (Bethesda Research Laboratories, Inc., Gaithersburg, Md.), resolved by electrophoresis through 0.8% agarose gels, and transferred to nitrocellulose paper by the Southern transfer method (12) . The presence of lambda (k)-or LAT-specific DNA within restriction fragments was detected by hybridization to nick-translated DNA probes, washing, and exposure to X-ray film (12) .
RNA produced in productively infected cells was analyzed as previously described (19) (20) (21) . Briefly, CV-1 cells were infected as described in the text. At the indicated times, cells were scraped into a guanidine thiocyanate lysis solution and RNA was sedimented by ultracentrifugation through a CsCl cushion. RNA pellets were suspended in water containing RNasin and resolved by electrophoresis through 1.2% agarose-formaldehyde gels followed by transfer to Gene Screen Plus (Dupont, NEN Research Products, Boston, Mass.). Filters were hybridized to nick-translated probes, washed, and autoradiographed (12) . RESULTS Construction and isolation of HSV-1 mutant with replacement mutation within LAT genes. The objective of this study was to begin a functional analysis of the LATs. A strategy was designed to construct an HSV-1 variant with a disruption of all three LATs (19, 26) and removal of the putative splice acceptor sites (27, 28) for the 1.45-to 1.5-kb LATs (19) . To construct such a virus, a 440-bp segment of bacteriophage lambda DNA was used to replace the 0.18-kb HSV-1 sequence between the two HpaI sites within the LATs (Fig. 1) . The presence of lambda DNA within the mutant genome provides an unambiguous marker of the mutant.
HSV-1 strain HFEM contains a deletion within the BamHI B fragment resulting in the loss of LATs from IRL. Therefore, HFEM contains only one copy of the LAT gene(s) (21) (Fig. 1) . Since HFEM establishes latency in mice (13, 19) , it was the target for our mutagenesis study.
Genomic HFEM DNA was cotransfected into CV-1 cells with linearized plasmid X-PstI-MluI. PstI-MluI plasmid contains 3 kb of HSV-1 DNA spanning the LAT gene(s) (Fig. 1) . X-PstI-MluI contains a deletion of 0.18 kb of HSV-1 DNA and an insertion of lambda DNA between the two HpaI sites. More than 200 plaques were picked from the transfection and examined for the presence of lambda DNA within the viral genome by dot-blot hybridization analysis. Figure 2 shows a representative dot-blot profile of 66 plaques occurring after transfection of HFEM genomic and X-PstI-MluI plasmid. Cell lysates were hybridized with HSV thymidine kinase gene (tk)-specific probe to detect HSV DNA ( Fig.  2A) . Paired spot blots corresponding to those above were hybridized to radioactive lambda DNA (Fig. 2B) . Only 1 of the 66 virus isolates in this figure reacted with the lambda probe (Fig. 2B, slot e4) . From all the blots performed, four plaques were positive for lambda sequences, and one, called TB1, was selected for further study after five series of plaque purifications.
To isolate rescuants of TB1 that contained intact LAT genes, we cotransfected TB1 genomic DNA into CV-1 cells with linearized PstI-MluI plasmid. Plaques that appeared after transfection of TB1 genomic and plasmid PstI-MluI DNA were isolated from several different wells of a culture tray and expanded for the determination of the presence of the 180-bp LAT sequence deleted in TB1 ( Fig. 2C and D) . HFEM, TB1 (Fig. 2C , slots B8 and B10, respectively), and all 15 isolates (Fig. 2C , slots Al to A12 and Bi to B3) were positive with a probe which hybridized to the HSV tk gene, thereby revealing the presence of HSV DNA. The HpaHpa-0.180 probe (specific for the 180-bp LAT sequence deleted in TB1) hybridized to HFEM (Fig. 2D, slot B9 ) but not to TB1 (Fig. 2D , slot Bll) isolates, as expected, and confirmed its specificity. Remarkably, 12 of 15 isolates from this marker transfer experiment were positive for the 180-bp LAT sequence (Fig. 2D , slots Al to A12). Two rescuants, TB1-R3 and -R17, were studied in more detail (see below).
To confirm that the lambda DNA present in TB1 did disrupt the LAT gene(s), genomic DNA from parental HFEM and TB1 was digested with restriction enzymes and analyzed by Southern blots. Hybridization of the HpaI-HpaI 0.180 probe to HpaI digestions of HFEM generated the expected 0.18-kb band that contained the HSV sequence deleted in plasmid X-PstI-MluI (Fig. 3A, lane 1) . The HpaHpa-0.180 probe also hybridized to the expected 9.2-kb fragment corresponding to BamHI-E present in BamHI digests of HFEM (Fig. 3A, lane 2) . The Hpa-Hpa-0.180 probe did not hybridize to TB1 DNA (Fig. 3A, lanes 3 and 4) .
However, a 0.440-kb HpaI fragment derived from TB1 DNA was recognized by the lambda probe (Fig. 3B, lane 3) .
Moreover, the lambda probe hybridized to 3.2-and 6.3-kb BamHI fragments of TB1 (Fig. 3B, lane 4) , as would be expected if the insertion of the altered LATs had occurred within the BamHI E fragment, because the lambda insert contains a BamHI site (Fig. 1) . In addition, the BamHI B probe hybridized to the 9.2-and 7-kb BamHI E and B fragments of HFEM, respectively (Fig. 3C, lane 1) , and hybridized to the 7-kb BamHI B fragment in the TB1 digest, indicating that this region of the TB1 genome was not altered. The (Fig. 3C, lane 2) which also hybridized to the lambda probe (Fig. 3B) . These results show that in TB1 the LAT 11 12 providing evidence that the defect in TBl has been corrected in both rescuants (Fig. 4B ). In addition, the alpha 0 trandii ib~~~~~~~~~~script, recognized by an alpha 0-specific probe that excludes LAT sequences, was equally abundant in HFEM-and TBlinfected cells (Fig. 4C) . This was important to show since alpha 0-negative mutants exhibit an altered latency phenotype (10) . Growth (Fig. 1). indicated that there is no difference between the reactivation profiles of the viruses. Strains 17+ and 1704 are shown for comparison (Fig. 6B) . 1704, a LAT variant unable to produce any LATs, had a much slower reactivation profile than its LAT+ parent, 17+.
The study conducted by Leib et al. (9) concluded that only 50% of the mice infected via the eye with the LAT-mutant yielded virus upon explant of ganglia, compared with 100% of the mice infected with wild-type virus. Since their assay employed homogenization of ganglia 5 days after explantation and the assay used here employed the continuous cocultivation of ganglia with indicator cells, we tested the possibility that assay methods would account for the different behaviors of TB1 and dlLAT 1.8. Therefore, 5 days after explant, ganglia from three mice latently infected with TB1 or HFEM were homogenized (six ganglia per virus) and tested for the presence of infectious virus. for HSV-1 to be shed from the ganglia and produce cytopathic effects in the indicator monolayer.
Characterization of LAT transcripts in peripheral ganglia. To determine the transcription of TB1 in latently infected mice, we processed ganglia for Northern (RNA) blots or in situ hybridization. Total RNAs were isolated from trigeminal ganglia of latently infected mice, Northern blotted, and hybridized to a PstI-MluI LAT probe (Fig. 7) . While transcripts of 2.0 and 1.5 kb were visible with RNAs extracted from trigeminal ganglia latently infected with F and HFEM (Fig. 7, lanes 1 and 2, respectively) , no herpesvirus-specific RNAs were detected in ganglia latently infected with TB1 (Fig. 7, lanes 3 to 5) . . : : e : . F : : . neurons in trigeminal ganglia obtained from mice latently infected with LAT+ strain 17+ (Fig. 8B) . In this experiment, strain 17+ was used as a positive control; however, HFEM yields similar results (unpublished observations). No hybridization signal was present in any ganglia from mice latently infected with TB1 (Fig. 8A) . A similar pattern of hybridization was obtained by using HSV-1 virion DNA as a probe (Fig. 8C and D) . That is, ganglia derived from mice infected with strain 17+ showed clear hybridization to the HSV genomic DNA probe, while no hybridization was seen with TB1 ganglia, even after long periods of exposure. Thus, using the most sensitive techniques available for studying expression, no HSV-1 transcription was detectable in the trigeminal ganglia of mice latently infected with TB1.
Characterization of reactivated virus. To confirm that reactivated TB1 virus remained unchanged during latent infection and reactivation, we recovered virus from reactivated explant tissue. Genomic DNA was prepared, digested with restriction enzymes, and resolved by agarose gel electrophoresis. There was no difference between the profile of TB1 used in the initial inoculum and that of the reactivated virus. Reactivated TB1 retained the lambda sequence in the appropriate position and remained negative for the region of the LAT deletion (data not shown).
DISCUSSION
This report extends previous observations that LATdefective HSV-1 is capable of establishing a latent infection in mice (7) (8) (9) 22) . The LAT mutant TB1 established a latent infection and reactivated from explanted trigeminal ganglia of mice with an efficiency and kinetics indistinguishable from those of the parental or revertant strain (Fig. 6 ). This is in contrast to the altered reactivation of LAT deletion mutants 1704 (22) and dlLAT 1.8 (9) as well as the impaired in vivo reactivation profile of the LAT-variant X10-13 (5) . TB1 differs from these null mutants in that it is still capable of making LAT region RNA (Fig. 4) , whereas dlLAT 1.8 and 1704 are unable to synthesize any LAT (9, 22) . Therefore, our data suggest that the role the LATs play in the reactivation process does not require the accumulation of full-length 1.5-to 2.0-kb transcripts in vivo and that the smaller 0.7-to 0.8-kb transcript made by TB1 may be functional during reactivation. RNA must have been synthesized from the LAT region but did not accumulate to detectable levels. The results with TB1 and RH142 suggest that (i) the 5' end of the LATs or its promoter sequence is sufficient to confer biological activity; (ii) a readthrough transcript might include the downstream LAT sequences that are present in both viruses; or (iii) the LATs do not play a role in explant reactivation. We think that the third possibility is unlikely based on the results with 1704 (22) and dlLAT 1.8 (9) .
As stated, an HSV LAT-virus, X10-13, established latency and reactivated with normal kinetics from explanted lumbosacral ganglia from mice infected through the footpad (8) vation processes in lumbosacral and trigeminal ganglia. However, the recent results of Hill et al. (5) showing that X10-13 does exhibit an impaired reactivation profile in rabbits in an eye model support the notion that LATs do play a role in reactivation from the trigeminal ganglia. Even though there are concerns about the relevance of explant reactivation assays, the results of in vivo studies with X10-13 reinforce the value of in vitro explant reactivation assays in predicting the behavior of LAT variants in vivo.
TB1 did not induce any detectable HSV-specific transcripts in ganglia from latently infected mice, showing that the disruption of LATs does not transcriptionally derepress other HSV genes ( Fig. 7 and 8 ). This argues against an antisense function for the LAT, as previously proposed (24) .
Furthermore, TB1 did not induce full-length LATs in tissue culture (Fig. 4) . Instead, a 0.7-to 0.8-kb transcript was produced in productively infected tissue culture cells that hybridized to probes that span the LAT region. These results do not exclude the possibility that a transcript is synthesized during latency that reads through the lambda insert or is located downstream of the insert. Another possibility is that the lambda-specific RNA in the transcript results in its rapid degradation in vivo. Further mapping of the TBl-specific VOL. 64, 1990 3424 BLOCK ET AL. (Fig. 1) We have also detected a large-size lowabundance transcript with the LAT probe in productively infected cells (15) . Furthermore, we have characterized by in situ hybridization a region of the genome adjacent to the LATs which appears to be weakly transcribed during latency (2, 15) . If these minor LATs are the functional LAT species and originate from the LAT promoter (1Sa), they might be produced at low levels by TB1, since the deletion in that virus is completely within the DNA coding for the 1.5-to 2.0-kb nuclear poly(A)-transcripts. Strain 1704 contains deletions of the LAT promoter regions, on the other hand, and would be unable to produce the minor LAT (1Sa). The failure to detect any LAT-specific transcription in TB1 latently infected tissue may be due to the very low abundance of the putative minor LAT.
LAT' rescuants could be isolated from TB1 after marker transfer of intact LAT sequences at a high frequency (approximately 70%). Under the conditions used in this study, the frequency of recombinant virus resulting from the marker transfer of HSV genes that do not confer any growth advantage is less than 2% (T. Block, unpublished observation). The fact that the majority of the plaques contained intact LAT genes after transfection of TB1 DNA and LATpositive plasmid suggests that a selection for intact LAT sequences had occurred. The difference between the forward (LAT-from LAT' virus) and back (LAT' from LATvirus) marker transfer frequencies is unlikely to be due to differences in the amount of HSV homology present in the rescuing plasmids or to plasmid concentration variability. The X-PstI-MluI and PstI-MluI plasmids each contain similar amounts of HSV sequence and were used over a range of concentrations in several transfections. Clearly, more work needs to be done to definitively map the reactivation phenotype of LAT deletion mutants such as 1704 and dlLAT 1.8.
In conclusion, TB1, a virus that cannot make intact LATs because of a replacement mutation, but does make a small RNA in tissue culture, reactivates from latently infected explanted ganglia in a manner indistinguishable from that of its parental strain, HFEM. The slow reactivation phenotypes associated with null mutants of the LAT gene must therefore be due to lesions that are not present in TB1.
